Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Prosensa Holding NV

+ Add to Watchlist

RNA:US

18.7400 USD 0.0600 0.32%

As of 20:10:00 ET on 01/30/2015.

Company Profile for Prosensa Holding NV (RNA)

Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

Contact Information

Prosensa Holding NV

JH Oortweg 21
Leiden, NL-2333 CH
Netherlands
Phone: 31-71-33-22-100
Fax: 31-71-33-22-088

Key Executives for Prosensa Holding NV (RNA)

Hans G C P SchikanCEO/Member-Mgmt BoardBerndt A E ModigCFO/Member-Mgmt Board
Willem W Van WeperenChief Commercial OfficerLuc DochezSenior VP:Bus Dev/Chief Bus Ofcr
Giles V CampionSenior VP:R&D/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil